Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||||
{[ item.p_purity ]} | {[ item.pr_size ]} | Login | Inquiry |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price) ]} |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price) ]} | {[ item.pr_usastock ]} | in stock Inquiry - | {[ item.pr_chinastock ]} | {[ item.pr_remark ]} in stock 1-2 weeks - Inquiry - | Login | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
CAS No. : | 37052-78-1 | MDL No. : | MFCD00134581 |
Formula : | C8H8N2OS | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | KOFBRZWVWJCLGM-UHFFFAOYSA-N |
M.W : | 180.23 | Pubchem ID : | 665603 |
Synonyms : |
|
Chemical Name : | 5-Methoxy-1H-benzo[d]imidazole-2-thiol |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95.1% | With potassium iodide; sodium hydroxide; In ethanol; at 15 - 55℃; for 0.5h;Inert atmosphere; Large scale; | (1) Add 102.0 kg of 95% ethanol to a 200 L reactor, and add 6.2 kg of pharmaceutically acceptable hydroxide under nitrogen protection.Sodium, stirred and dissolved. The temperature of the reaction solution was controlled at 15 to 25 C, and 11.9 kg of 2-mercapto-5-methoxybenzimidazole, 15.0 kg of Omega chloride (ie 67.87 mol) and 0.3 kg of potassium iodide were sequentially added.Slowly raise the temperature to 50 C -55 C, keep the reaction for 30 minutes;(wherein the molar ratio of 2-mercapto-5-methoxybenzimidazole, Omega chloride, sodium hydroxide and potassium iodide is 1:1.02: 2.27: 0.027; 95% ethanol is 7 times the mass of Omega chloride, or 2-mercapto-5-methoxybenzimidazole8.8 times the quality).(2) Sampling was monitored by TLC method (developing agent ethyl acetate: n-hexane = 1:1) 2-mercapto-5-methoxybenzoThe imidazole spots disappeared and the reaction was terminated and post-treatment; if 2-mercapto-5-methoxybenzimidazole spots were still visible, the reaction was continued and samples were taken every 15 minutes for monitoring until the spots disappeared.(3) Concentrated under reduced pressure at 45 to 50 C to remove ethanol. 83.3 kg of ice water was added to the residue, and the pH was adjusted to about 7 with hydrochloric acid, wherein the amount of ice water added was 5.55 times the mass of Ogilvy & Mather.(4) 30 kg of dichloromethane was added, stirred for 15 minutes, and the layers were allowed to stand, and the dichloromethane layer was separated; the aqueous layer was extracted three times with dichloromethane (16.7 kg*3 each time).The methylene chloride phase was combined, and the purified water was washed twice (33.3 kg*2), and washed with saturated brine.It was dried twice (32.5 kg * 2) and 10 kg of anhydrous sodium sulfate for 2 hours. Filtration and concentration of the filtrate under reduced pressure gave 21.62 kg of intermediate 1 (ie, containing omeprazole sulphide 64.54 mol, as shown in the purity of 98.383% (see Figure 1).Light yellow viscous). The yield was 64.54 / 67.87 = 95.1%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With N-ethyl-N,N-diisopropylamine; In 1-methyl-pyrrolidin-2-one; for 20h;Combinatorial reaction / High throughput screening (HTS); | Each resin from Step 3 was distributed into 24 fritted syringes (Torvig, 50 mg each, 50 mumol), for a total of 96 syringes, and was swelled in NMP (1 mL) for 30 min. The solvent was removed by filtration. Twenty-four solutions of the building blocks listed below (10 mmol each) and DIBA (3.5 mL, 20 mmol) in NMP (10 mL) were prepared. 3 mL of the 24 solutions was added to the 24 syringes for each resin from Step 3, accordingly. The suspensions were then shaken for 20 h on a Titer Plate Shaker. The reaction mixture was filtered and washed 5 times with methylene chloride (5 mL), 3 times with THF (5 mL), 3 times THF/H2O (3/1 v/v, 5 mL), and 3 times with THF (5 mL). The resins were then dried overnight under vacuum. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With N-ethyl-N,N-diisopropylamine; In 1-methyl-pyrrolidin-2-one; for 20h;Combinatorial reaction / High throughput screening (HTS); | Each resin from Step 3 was distributed into 24 fritted syringes (Torvig, 50 mg each, 50 mumol), for a total of 96 syringes, and was swelled in NMP (1 mL) for 30 min. The solvent was removed by filtration. Twenty-four solutions of the building blocks listed below (10 mmol each) and DIBA (3.5 mL, 20 mmol) in NMP (10 mL) were prepared. 3 mL of the 24 solutions was added to the 24 syringes for each resin from Step 3, accordingly. The suspensions were then shaken for 20 h on a Titer Plate Shaker. The reaction mixture was filtered and washed 5 times with methylene chloride (5 mL), 3 times with THF (5 mL), 3 times THF/H2O (3/1 v/v, 5 mL), and 3 times with THF (5 mL). The resins were then dried overnight under vacuum. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With N-ethyl-N,N-diisopropylamine; In 1-methyl-pyrrolidin-2-one; for 20h;Combinatorial reaction / High throughput screening (HTS); | Each resin from Step 3 was distributed into 24 fritted syringes (Torvig, 50 mg each, 50 mumol), for a total of 96 syringes, and was swelled in NMP (1 mL) for 30 min. The solvent was removed by filtration. Twenty-four solutions of the building blocks listed below (10 mmol each) and DIBA (3.5 mL, 20 mmol) in NMP (10 mL) were prepared. 3 mL of the 24 solutions was added to the 24 syringes for each resin from Step 3, accordingly. The suspensions were then shaken for 20 h on a Titer Plate Shaker. The reaction mixture was filtered and washed 5 times with methylene chloride (5 mL), 3 times with THF (5 mL), 3 times THF/H2O (3/1 v/v, 5 mL), and 3 times with THF (5 mL). The resins were then dried overnight under vacuum. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With N-ethyl-N,N-diisopropylamine; In 1-methyl-pyrrolidin-2-one; for 20h;Combinatorial reaction / High throughput screening (HTS); | Each resin from Step 3 was distributed into 24 fritted syringes (Torvig, 50 mg each, 50 mumol), for a total of 96 syringes, and was swelled in NMP (1 mL) for 30 min. The solvent was removed by filtration. Twenty-four solutions of the building blocks listed below (10 mmol each) and DIBA (3.5 mL, 20 mmol) in NMP (10 mL) were prepared. 3 mL of the 24 solutions was added to the 24 syringes for each resin from Step 3, accordingly. The suspensions were then shaken for 20 h on a Titer Plate Shaker. The reaction mixture was filtered and washed 5 times with methylene chloride (5 mL), 3 times with THF (5 mL), 3 times THF/H2O (3/1 v/v, 5 mL), and 3 times with THF (5 mL). The resins were then dried overnight under vacuum. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With tetrabutylammomium bromide; edetate disodium; sodium hydroxide; In dichloromethane; water;pH 10; | Step S1: 80.0 g (0.36 mol) of 4-methoxy-3,5-dimethyl-2-chloromethylpyridine hydrochloride (Compound I) was added to 480 mL of dichloromethane.0.2 g of disodium edetate was dissolved in 80 mL of water and added to the reaction solution.Step S2: After stirring and dissolving, 64.0 g (0.356 mol) was added.2-mercapto-5-methoxybenzimidazole (formula II),2.0 g (0.006 mol, 2% molar equivalent) of tetrabutylammonium bromide,Sodium hydroxide adjusts the pH to 10,Stir until the reaction is over,Liquid separation,extraction,washing,dry,concentrate,a compound of formula III,Calculated in 100% yield.Sodium hydroxide adjusts the pH to 10,The specific adjustment method is:Adjust the pH value in sections,Fine-tuning with 10% sodium hydroxide in the early stage of the reaction;In the middle of the reaction, it was adjusted by using 15% sodium hydroxide.Let it reach a pH of 8,Add 15% sodium hydroxide every 10 minutes.This kind of benefit is adjusted more fully,Can better observe the effect of the adjustment,Make its PH reach 9;In the later part of the reaction, it was adjusted by using 20% hydrogen peroxide.Make it PH to 10,The way the adjustment is added when it is interrupted,Add sodium hydroxide every 20 minutes;By adjusting the pH value in sections,Thereby making the adjusted pH more precise,More saving on sodium hydroxide,Save the production costs of the enterprise. |
95.2% | With sodium hydroxide; In methanol; water;Reflux; | To a 1000 ml three-mouth flask is added 2-mercapto-5-methoxy benzimidazole 50.0g (0.28 muM), 500 ml of water and sodium hydroxide 22g (0.56 muM), after stirring dissolves clear slowly dropping 2-(chloromethyl)-4-methoxy-3,5-dimethyl pyridine hydrochloride 62g (0.28 muM) with methanol 300 ml of solution, stirring and heating to reflux the reaction, TLC monitoring raw material the reaction is complete. By reducing pressure methanol, water 200 ml, and dichloromethane is used for 300 ml * 3 extraction, the combined organic phase into the 2500 ml single-port in the bottle, the pressure off the solvent, adding petroleum ether to the residue in 1000 ml, lowering the temperature to 5 - 10 C stirring crystallization, extraction, drying, to obtain white solid the ufiprazole 87g, yield 95.2%. |
94% | With sodium hydroxide; In ethanol; acetone; at 40 - 45℃; for 3h;Large scale; | The reactor was added anhydrous ethanol 12.0kg, stirring, adding sodium hydroxide 1.09kg (27.25mol, 2.05eq) After stirring for 30 min, the internal temperature was controlled at 20-25 C. 2.40 kg (13.32 mol, 1.00 eq) of EL2,EL3 3.10kg (13.96mol, 1.05eq), acetone 4.0kg, the reaction was heated to an internal temperature of 40 ~ 45 ,Reaction 3h, TLC monitoring EL2 disappeared, the reaction was complete. The reaction liquid temperature was lowered to 25 ~ 30 ,After stirring for 30 min, insoluble materials were removed by filtration, the filter cake was washed once with 1.5 kg of acetone,The filtrate was concentrated under reduced pressure (bath temperature 40 ~ 45 ), the residue was added ethyl acetate 13.2kg, cooled to 0 ~ 5 ,Stir 3h, filter. The filter cake was washed once with 1.5 kg of ethyl acetate at 0-10 C,40 ~ 45 vacuum drying 8 to 10 hours. 4.14 kg of Intermediate 1 (EL1) was obtained with a yield of 94% and a purity of 95.5% by HPLC. |
94% | With sodium hydroxide; In ethanol; acetone; at 20 - 45℃; for 3h;Large scale; | The reactor was filled with 12.0 kg of absolute ethanol.Stir and add 1.09 kg of sodium hydroxide (27.25 mol, 2.05 eq). After stirring for 30 minutes, the internal temperature is controlled at 20 to 25C.EL2 2.40 kg (13.32 mol, 1.00 eq) and EL3 3.10 kg (13.96 mol, 1.05 eq) were successively added.Acetone 4.0kg, the reaction solution was heated to an internal temperature of 40 to 45C, and the reaction was conducted for 3 hours. TLC monitored EL2 disappeared. The reaction is complete. The internal temperature of the reaction solution is reduced to 25 to 30C.After stirring for 30 minutes, the insoluble material was removed by filtration.The filter cake was washed once with acetone 1.5 kg, and the filtrate was concentrated under reduced pressure (bath temperature 40-45C).The residue was added with 13.2 kg of ethyl acetate and cooled down to 0-5C.Stir for 3h and filter. The filter cake was washed once with ethyl acetate of 0-10 C 1.5 kg,40 ~ 45 C vacuum drying 8 ~ 10 hours. Obtained 4.14 kg of Intermediate 1 (EL1) in 94% yield.Purity was 95.5% by HPLC. |
90% | With sodium carbonate; In methanol;Reflux; | Methanol was stirred at 25-35 0C and cooled to 20-25 0C. To the cold solution, 2-chloromethyl-3,5-dimethyl-4-methoxy-pyridine hydrochloride (1 mol), 2-mercapto-5-methoxy-benzimidazole (1 mol) and sodium carbonate (2.2 mol) and heated to reflux temperature. After completion of the reaction, the by-product formed was removed by filtration. Methanol was removed by distillation from the filtrate until small amount of methanol remains. The residue was dissolved in toluene and washed with aqueous solution of sodium carbonate. The organic layer was distilled under vacuum and cooled. To the residue toluene was added and seeded with qualified compound of formula (II). The obtained solid was filtered, washed with toluene and dried to obtain title compound. Yield: 80-90 %; Purity: 99%. |
With sodium hydroxide; In ethanol; water; for 2h;Heating / reflux;Product distribution / selectivity; | Reference Example 1; (according to EP5129):Preparation of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)thio]-1 H- benzimidazole Form I2-chloromethyl-3,5-dimethyl-4-methoxy pyridine hydrochloride (25 g) and 2-mercapto-5- methoxy benzimidazole (20 g) were dissolved in 95% ethanol (200 ml). To this sodium hydroxide solution (8 g of sodium hydroxide dissolved in 20 ml of water) was added and refluxed for 2 hours. The sodium chloride formed was filtered off and the solution was concentrated to residue. The residue was then recrystallised from 70% of ethanol (30 ml) to yield 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)thio]-1 H-benzimidazole Form I (7 g). Example 2: <n="21"/>Preparation of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)thio]-1 H- benzimidazole Form I2-chloromethyl-3,5-dimethyl-4-methoxy pyridine hydrochloride (50 g) and 2-mercapto-5- methoxy benzimidazole (40 g) were dissolved in 95% ethanol (400 ml). To this sodium hydroxide solution (16 g of sodium hydroxide dissolved in 40 ml of water) was added and refluxed for 2 hours. The sodium chloride formed was filtered off and the solution was concentrated to residue. The residue was then recrystallised from 70% methanol (60 ml) at50-550C, chilled to -5 to O0C and maintained for 2 hours. The solid was filtered and dried at 40-450C under vacuum to yield 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2- pyridinyl)methyl)thio]-1 H-benzimidazole Form I (21.0 g). Example 3:Preparation of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)thio]-1 H- benzimidazole Form I2-chloromethyl-3,5-dimethyl-4-methoxy pyridine hydrochloride (100 g) and 2-mercapto-5- methoxy benzimidazole (80 g) were dissolved in 95% ethanol (800 ml). To this sodium hydroxide solution (32 g of sodium hydroxide dissolved in 80 ml of water) was added and refluxed for 2 hours. The sodium chloride formed was filtered off and the solution was concentrated to residue. The residue was then dissolved in methylene chloride (120 ml) and stripped off methylene chloride with ethyl acetate (40 ml). Further ethyl acetate (160 ml) was added and heated to dissolve at 50-550C1 cooled to room temperature, chilled to - 5 to O0C, maintained for 1 hour. The solid was filtered and dried at 40-450C under vacuum to yield 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)thio]-1 H-benzimidazole Form I (47.0 g). | |
With sodium hydroxide; tetrabutylammomium bromide; In dichloromethane; water; at 5 - 20℃; for 2h;pH 10.0 - 10.5; | Example 4:Preparation of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)thio]-1 H- benzimidazole Form Il <n="22"/>2-hydroxymethyl-3,5-dimethyl-4-methoxy pyridine hydrochloride (300 g) was charged to dichloromethane (1770 ml) and cooled to 15 - 20 C. Thionyl chloride (240 g) was added slowly at 15 to 20 C and the contents were stirred at 25 to 30 C for 1 hour. After reaction 5 completion, water (300 ml) was added at 15 to 20 C and allowed to attain 25 to 3O0C. To this reaction mass 2-mercapto-5-methoxy benzimidazole (252 g) and tetrabutyl ammonium bromide (6 g) was added, and the pH of the reaction mass was adjusted to 10.0 to 10.5 at 5 to 15C using 30% sodium hydroxide solution and stirred for 2 hours at 15 to 2O0C maintaining pH 10.0 -to 10.5. After reaction completion the dichloromethane10 layer was separated and the aqueous layer was extracted with dichloromethane (370 ml x 2). The dichloromethane layer was then washed with water until the pH of the aqueous layer was 7.0 to 7.5, dried over sodium sulphate and partially concentrated at temperature below 50 C under vacuum. Ethyl acetate (240 ml) was added and stripped off to remove traces of dichloromethane, further ethyl acetate (800 ml) was added and heated to 50 to15 60 C, cooled to room temperature, chilled to 10 to -5 C and maintained for 1 hour. The product was then filtered, washed with chilled ethyl acetate (200 ml). The product was then dried at 30 to 35 C to yield 5-methoxy-2-[[(4-methoxy-3,5-dimethyl~2- pyridinyl)methyl)thio]-1 H benzimidazole form II (392 g, 80.6% yield). | |
With sodium hydroxide; In water; ethyl acetate; at 25 - 55℃; for 2.5h; | 2-(chloromethyl)-3,5-dimethyl-4-methoxy pyridine hydrochloride (IV) (100.0 g) and 2-mercapto-5-methoxy benzimidazole (III) (81.0 g) were taken in RBF. Ethyl Acetate (400 mL) was added to RBF at 25C to 350C. Sodium hydroxide (50.0 g) solution in water (200 mL) was added to the reaction mass within 30 mins. The reaction0 mass was stirred for 1 hr and heated to 500C to 55C for 1 hr. After completion of the reaction on TLC, reaction mass was cooled to 250C to 300C. Water (200 mL) was added and stirred to separate the organic and aqueous layers. Aqueous layer was extracted with ethyl acetate (150 mL) and separated. The combined ethyl acetate layer was charcaolised (5.0 g) and stirred for 30 mins. The reaction mass was filtered through hyflow bed and washed with ethyl acetate (50 mL). The pH of the organic layer was adjusted to about 6.0 to 6.5 with acetic acid (0.5 mL) and cooled to 5C to 100C.Sodium molybdate (1.33 g) solution in water (13.2 mL) was added to the reaction mass and stirred for 15 mins. 50% hydrogen peroxide (37.0 g) was added into the reaction mass within 1.5 hrs at 5C to 12C. The reaction mass was stirred for 5 hrs.After completion of the reaction on TLC, the reaction mass is treated with sodium thiosulphate (11.0 g) solution in water (11.0 mL). Sodium hydroxide (6.0 g) solution in water (6 mL) was added into the reaction mass to adjust the pH of about 7.0 to 7.5. The reaction mass was further cooled to 00C to 5C and stirred for 60 mins. The product was filtered and washed with mixture of methanol (50 mL) and water (50 mL) followed by washing with chilled ethyl acetate (75 mL).Crude omeprazole (120.0 g) wet-cake as obtained above and methanol (160 mL) were taken in another RBF at 25C to 35C. Sodium hydroxide (15.8 g) solution in water (176 mL) was added into the reaction mass. Charcaol (2.6 g) was added and stirred for 30 mins. The reaction mass was filtered on hyflow bed and washed with mixture of methanol (10 mL) and water (10 mL). The filtrate was treated with sodium hydrosulphite (2.0 g). The reaction mass was slowly treated with acetic acid (22.5 mL) to adjust the pH of about 7.5 to 7.9. The product was filtered and washed with water(244 mL) and dried at 400C to 45C to obtain 100.0 g crystalline omeprazole Form B. Yield 68% based on input 2-(chloromethyl)-3,5-dimethyl-4-methoxy pyridine hydrochloride (IV).HPLC purity: 99.87%Individual Impurities are as under:Im purity- A at RRT 0.44 : 0.01% Impurity-B at RRT 0.46 : Not detectedImpuriry-C at RRT 0.80 : 0.02%Impurity-D at RRT 0.90 : Not detectedImpurity-E at RRT 3.26 : Not detectedUnk Impurity: 0.03% Total Impurities : 0.13%Impurity-A: 5-methoxy- 1 H-benzimidazole-2-thiolImpurity-B: 2-[(R,S)]-[(3,5-dimethylpyridine-2-yl)methyl]sulphinyl]-5-methoxy-lH- benzimidazole Impurity-C: 5-methoxy-2[[4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulphanyl]- lH-benzimidazole [Omeprazole Sulfide]Impurity-D: 5-methoxy-2[[4-methoxy-3,5-dimethylpyridin-2-yl)methyl]suIphonyl]- lH-benzimidazole [Omeprazole Sulfone] Impurity-E: 4-methoxy-2-[[(R,S)-(5-methoxy- 1 H-benzimidazole-2-yl)- sulphinyl]methyl)-3,5-dimethylpyridine- 1 -oxide [Omeprazole N-Oxide] | |
130 g | With sodium hydroxide; In methanol; water; at 30 - 35℃; | 2-mercapto-5-methoxy benzimidazole (83.10 gm) was added at 30-35C to a solution of NaOH (42 gm) in Methanol (200 ml) and Water (100 ml) to form a 1st reaction mass. A solution of 2-Chloromethyl-3,5-dimethyl-4-methoxy pyridine hydrochloride ( 100 gm) in methanol (50 ml) and water (150 ml) mixture was added to the 1st reaction mass in 90- 120 min at 30-35C and the reaction mass stirred for 10-15 hrs and the reaction followed by TLC and HPLC.The reaction mass was worked up by addition of Water(900 ml), stirred for 2 hours, and filtered, washed with water(2x300 ml); suck dried, filtered and dried at 42-46C for 24-30 hrs in an oven to afford stage- 1 intermediate with M./C content < 0.5% and a Dry Wt: - 130 gm |
With sodium hydroxide; In methanol; at 86℃; for 2.5h; | Solubility in methanol is added to 70% sodium hydroxide solution, after mixing, adding stirring 2-mercapto-5-methoxy-benzimidazole, and then continue adding 2-chloromethyl -3, 5-dimethyl-4-methoxy pyridine hydrochloride, the mixed temperature of the solution rises to 86 C, thermal insulation 2.5h, wait for the temperature to drop to 22 C time, concentrated under reduced pressure, by adding dichloromethane, extraction, water washing, the recovered methylene chloride, by adding ethyl acetate, the 18 C conditions, and stirring crystallization 4.5h, centrifugal, 47 C drying under the conditions, obtain amazingel sulfide; | |
With sodium hydroxide; In dichloromethane; water; at 55℃; for 2h; | A solution of 11.1 g of 2-chloromethyl-3,5-dimethyl-4-methoxypyridine hydrochloride And 2-mercapto-5-methoxybenzimidazole 9.8 g was added to a 500 ml three-necked flask,Add 150 ml of methylene chloride, the reaction solution is white turbid liquid,The water bath was heated to 55 C. At this temperature,Dropping the concentration of 17% aqueous sodium hydroxide solution, drop finished, the reaction solution gradually white turbid liquid into a light yellow transparent liquid, 55 C under the time reaction 2 hours, Samples were taken as 2-chloromethyl-3,5-dimethyl-4-methoxypyridine hydrochloride Content below 0.5%The reaction was stopped and the reaction solution was allowed to cool to room temperature and washed three times with 150 ml of purified water to separate the organic phase. | |
With sodium hydroxide; In dichloromethane; water; at 0 - 5℃; for 2h;Reflux; | 1) will5-methoxy-2-mercaptobenzimidazole 100g dispersed in 500mlIn dichloromethane,Cool down to 0 ~ 5 ° C,To the above system, 44 ml of an aqueous solution of 15 wtpercent sodium hydroxide was added dropwise, and after the addition was completed,Temperature control 0 ~ 5 ° C,Continue to drop by 125g2-Chloromethyl-3,5-dimethyl-4-methoxypyridine hydrochloride and 125 mla solution made of water,After the addition is completed,Warming up to reflux for 2 h,Then cool down to 15 ° C,Let stand for liquid separation,200 ml of water was added to the dichloromethane phase.Stir for 15min,The liquid phase was separated to give a dichloromethane phase. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Pyrmethyl alcohol (8.8 g, 52.6 mmol) was dissolved in toluene (75 [ML,] water content 0.12 mg/ml) moistened with water [(180 GEL,] 10 mmol) at room temperature. To the stirred solution, at [25-30 °C,] thionyl chloride (8.15 g, 68.5 mmole) was added slowly over 60 min. (flow rate of 0.083 ml/min). Conversion of the reaction was analysed with HPLC as in Example 1. Conversion over 99.5percent. Water (2.3 ml) was added to quench any excess of thionyl chloride. An alkaline (13.5 g, 168.3 mmol 50 percent w/w sodium hydroxide) aqueous (80 ml) solution of metmercazole (9.8 g, 54.2 mmol) was added followed by additional sodium hydroxide (8.8 g, 110.5 mmol, 50 percent w/w sodium hydroxide) to reach pH>12.5. The temperature was allowed to increase to 45 °C during the additions. The reaction mixture was left with vigorous stirring for approximately two hours at [45 °C.] The agitating was interrupted and the phases were left to separate. The aqueous phase was discarded. The organic phase, comprising pyrmetazole, was washed with water and was analysed for residues of pyrmethyl alcohol (less than 0.1 percent mol).; Example 5 Pyrmethyl alcohol (8.8 g, 52.6 mmol) was dissolved in toluene (75 ml, water content 0.12 mg/ml) moistened with water [(375) J. I,] 20.8 mmol) at room temperature. To the stirred solution, at [25-35 °C,] thionyl chloride (9.33 g, 78.4 mmol) was added slowly over 60 min. (flow rate of 0.095 ml/min). Conversion of the reaction was analysed with HPLC as in Example 1. Conversion over 99.5 percent. The synthesis continued in the same way as described in Example 4. The product phase, comprising pyrmetazole, was analysed for residue of pyrmethyl alcohol (less than 0.1 percent mol). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In a 3000 mL three-necked round bottom flask,Add 270 ml of methanol,2-Mercapto-5-methoxybenzimidazole 90. 0 g (0.50 mol),Stirring,Add an aqueous sodium hydroxide solution (40.0 g sodium hydroxide/100 ml purified water).Stir the reaction at room temperature for 1 hour.2-chloromethyl-3,5-dimethyl-4-methoxypyridine hydrochloride 110 g (0.50 mol) was added,Methyl tert-butyl ether (900 ml) was heated to 35-45 °C for 3 hours.After the reaction,Cool the feed to room temperature,Purified water 250 ml*2 was added twice to the remaining stock solution.Obtained methyl sulfide tert-butyl ether solution,The water bath is heated to 50-60°C,Addition of 62.5 g (0.30 mol) of D-(-)-diethyl tartrate,Tetraisopropyl titanate 43.0 g (0.15 mol),Insulation for 1 hourAfter cooling to 25-35°C,Triethylamine 15.0 g (0.15 mol) was added,72.0 g (0.475 mol) of cumene hydroperoxide was added dropwise.5h, heat preservation reactionAfter the reaction,Add 15percent ammonia water 400ml to the reaction solution.Stir for 20min,Extraction liquid, The organic layer was extracted twice with 15percent aqueous ammonia 400ml*2.Combined ammonia layer,Add activated carbon 12 g to decolorize at room temperature for 4 hours.filter,Ammonia layer is added with ethyl acetate 900 ml,Ice bath cooling to 5-15 °C,The glacial acetic acid was added dropwise to adjust the pH to 7. 5-8. 5,Dividing fluid,The aqueous layer was extracted with ethyl acetate 450ml for the second extraction.Combine the ethyl acetate layers,Wash 400 ml*2 twice with saturated saline solution.Ethyl acetate extraction phase,Temperature control 35 ~ 45 °C vacuum concentration,Light brown oil 148.2 g,Add acetone 900 ml,Stir so that the oil is completely dissolved,Transfer the feed solution to a 2000 ml three-neck round bottom flask.Sodium hydroxide solution (18.1 g of sodium hydroxide/1. 8 g of purified water) was added,Heating reflux 60min,The crystal was dropped to 0-10°C and stirred for 6h.Suction filtrationAcetone 50ml wash cake,Filter cake 35-45 °C / -0. 095MPa vacuum drying 12h,120.7 g of esomeprazole sodium was obtained.Yield 65.7percent.HPLC: 99.6percent,Eepercent: 99.7percent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
60% | In toluene; for 4h;Reflux; | At room temperature 4-methoxy-3,5-dimethylpyridine N-oxide (445 mg, 2.66 mmol) dissolved in ethyl acetate (6 mL).Trifluoroacetic anhydride (1.4 g, 6.65 mmol) was then added.The reaction was refluxed for three hours.The reaction was monitored by TLC, and the reaction mixture was concentrated to give a trifluoroacetate intermediate.The reaction intermediate was dissolved in toluene (3 ml), then 2-mercapto-5-methoxybenzimidazole (480 mg, 2.66 mmol) was added, and the reaction was heated under reflux for four hours.The reaction was terminated by TLC, and the reaction solution was adjusted to pH 7-8 with a saturated aqueous sodium carbonate solution, and then separated.Adding the aqueous extracted three times with ethyl acetate, the organic phase with saturated brine, dried over anhydrous sodium sulfate, and concentratedThe target product omeprazole thioether (519 mg, 60percent yield) was obtained by silica gel column chromatography using PE~PE/EA (10:1 to 1:3) as mobile phase. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sodium hydroxide; In methanol; water; for 1h;Reflux; | In 3000mL neck round bottom flask was added 2-chloro-3,5-dimethyl-4-methoxypyridine hydrochloride 123.3g (0.555mol) and methanol 1500ml, with stirring, was added 2-mercapto-5-methoxy-benzimidazole 100.0g (0.555mol), was added dropwise a solution of sodium hydroxide (NaOH 44.4g/150ml purified water), heated at reflux dropwise IH water bath, the reaction was complete, the material was transferred into rotation evaporator, temperature 50-55 °C rotation about 1/2 of the solvent was distilled off, 1000ml purified water was added to the remaining feed solution, 250ml of ethyl acetate, stirred for 20min, extracted liquid separation, the aqueous layer was re-extracted with ethyl acetate 250ml was extracted once with ethyl acetate layers were combined, heated in a water bath to 50-60 °C, was added D-(-)-diethyl tartrate 68.7g (0.333mol), tetraisopropyl titanate 47.2 g (0.166 mol), stirred insulation 1h, after cooling to 30-40 °C, was added diisopropylethyl amine 21.4g (0.166mol), cumyl hydroperoxide was added dropwise 84.5g (0.555mol), reaction was complete insulation dropwise 1.5h, the reaction completion, 12.5percent aqueous ammonia 500ml was added to the reaction mixture, stirred for 20min, extract liquid separation, the organic layer was extracted twice with 12.5percent aqueous ammonia 500ml × 2, ammonia layers were combined, washed once with 400ml ethyl acetate, aqueous ammonia layer is taken, ethyl acetate was added 1000ml, cooled to ice bath at 5-15 °C was added dropwise glacial acetic acid pH adjusted to 7.5-8.5, dropwise liquid separation, the aqueous layer was extracted a second 600ml ethyl acetate was added, combined ethyl acetate acetate layer was washed with saturated brine 2 times 500ml × 2, ethyl acetate layer was taken, dried over anhydrous sodium sulfate, the drying agent was filtered off, the filtrate was rotary evaporator temperature 50-55 °C to afford dark purple oil was 176.3 g, was added acetone 1000ml, the whole was stirred to dissolve the oil, the material was transferred into 2000ml three neck round bottom flask, was added sodium hydroxide solution (sodium hydroxide 20.4g / 20.4 g of purified water), heated at reflux for 30min, decreased to 5-10 crystallization was stirred 6h, filtered off with suction, washed with 50ml of acetone filter cake 35-45 / -0.095MPa dried in vacuo 12h, to give esomeprazole sodium 145.9 g, yield 71.57percent. HPLC: 95.3percent, largest single hetero 4.1percent, eepercent: 97.3percent. |
[ 97963-62-7 ]
5-(Difluoromethoxy)-1H-benzo[d]imidazole-2-thiol
Similarity: 0.90
[ 6232-91-3 ]
5-Methoxy-1H-benzimidazole-2-ylamine
Similarity: 0.78
[ 4887-80-3 ]
5-Methoxy-1H-benzo[d]imidazole
Similarity: 0.71
[ 10394-39-5 ]
5-Methoxy-1-methyl-1H-benzo[d]imidazole
Similarity: 0.69
[ 27080-53-1 ]
7-Methoxy-1H-benzo[d]imidazole
Similarity: 0.68
[ 97963-62-7 ]
5-(Difluoromethoxy)-1H-benzo[d]imidazole-2-thiol
Similarity: 0.90
[ 92807-02-8 ]
Methyl 2-mercapto-1H-benzo[d]imidazole-4-carboxylate
Similarity: 0.60
[ 19462-98-7 ]
5,6-Dichloro-1H-benzo[d]imidazole-2-thiol
Similarity: 0.57
[ 68892-07-9 ]
Methyl 2-mercapto-1-methyl-1H-imidazole-5-carboxylate
Similarity: 0.54
[ 97963-62-7 ]
5-(Difluoromethoxy)-1H-benzo[d]imidazole-2-thiol
Similarity: 0.90
[ 6232-91-3 ]
5-Methoxy-1H-benzimidazole-2-ylamine
Similarity: 0.78
[ 4887-80-3 ]
5-Methoxy-1H-benzo[d]imidazole
Similarity: 0.71
[ 41292-66-4 ]
2-Methyl-1H-benzo[d]imidazol-5-ol
Similarity: 0.70
[ 10394-39-5 ]
5-Methoxy-1-methyl-1H-benzo[d]imidazole
Similarity: 0.69
感谢您访问我们的网站,您可能还对以下资源感兴趣:
成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天